FindTrial
Sign In

comparitive study of two antifungal medicines in treatment of superficial fungal infection

Comparative study of efficacy of itraconazole and terbinafine with different doses and combination in the treatment of Tinea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/015063
Enrollment
275
Registered
2018-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Fungal infected stable patients.

Interventions

Intervention1: different doses and combination of two systemic antifungal agents.: follow up every 2 weeks to see clinical improvement for 8 weeks. If there is no improvement after 4 weeks of treatmen

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Tinea cruris Tinea corporis Tinea faciei

Exclusion criteria

Exclusion criteria: weight more than 80 kg Any other co-morbidities like hepatic disorders, renal disorders, cardiac disorders, etc. history of oral antifungal agents within one month of start of study. pregnancy. lactation.

Design outcomes

Primary

MeasureTime frame
Complete clearance of skin lesionsTimepoint: every 2 weeks for 8 weeks—

Secondary

MeasureTime frame
Experienced as primary outcome.Timepoint: Every 2 weeks for 8 weeks.—

Countries

India

Contacts

Public ContactSatyendra Kumar Singh

Institute of Medical Sciences

drsatyendraderma@gmail.com9198120582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026